Physician and Media Personality Dr. Drew Pinsky, Dr. Drew, Joins Aditx Therapeutics as Senior Advisor to AditxtScore™ for Scoring the Immune System
Aditxt, Inc. (ADTX)
Company Research
Source: GlobeNewswire
Will Serve as Advisor and Brand Ambassador to Overall Platform and Individual Applications Dr. Drew Pinsky Loma Linda, CA, Sept. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has appointed Dr. Drew as Senior Advisor, AditxtScore™, effective September 1, 2020. Dr. Drew, a practicing physician, internist, and an addiction medicine specialist, will advise on the development of AditxtScore™ platform, and its various potential applications including possibly scoring immunity to COVID-19 and other infectious diseases, as well as autoimmune dis
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Aditxt signs agreement to acquire Appili Therapeutics [Seeking Alpha]Seeking Alpha
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) [Yahoo! Finance]Yahoo! Finance
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)Business Wire
- Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc. [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc. [Yahoo! Finance]Yahoo! Finance
ADTX
Sec Filings
- 4/16/24 - Form 10-K
- 4/12/24 - Form 8-K
- 4/4/24 - Form 8-K
- ADTX's page on the SEC website